RARA CRAFT DATABASE for FDA Medical Devices
510(k)K190937

FDA DEVICE FACTS

Echelon Endopath Staple Line Reinforcement

Ethicon Endo-Surgery, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 14, 2019PRODUCT CODEOXC

Indications for use

ECHELON ENDOPATH Staple Line Reinforcement is indicated for use in surgical procedures in which soft tissue transection or resection with staple line reinforcement is needed. ECHELON ENDOPATH Staple Line Reinforcement can be used for reinforcement of staple lines during lung resection and bariatric surgical procedures. The device can also be used for reinforcement of staple lines during gastric, small bowel and colorectal procedures. Summary of Similarities and Differences in Technological Characteristics Staple line reinforcement is the technological principle for both the Subject Endopath Echelon Staple Line Reinforcement and the Predicate Gore® Seamguard® Reinforcement device. It is based on the use of applying an absorbable material, also known as a buttress, as a reinforcement to the transected surgical staple line in soft tissue. At a high level, the Subject and Predicate Devices are based on the following same technological elements:

• Staple line reinforcement device is applied to a surgical stapler

• Staple line reinforcement and stapler are positioned on the desired anatomical area to be transected

• Stapler is fired, knife proceeds to transect tissue, and staples with buttress are applied to the tissue

• Absorbable implant reinforces tissue and helps to secure the staple line The Endopath Echelon Staple Line Reinforcement differs from Predicate Gore® Seamguard® Reinforcement device in the Steps for Use to load the buttress device onto the surgical stapler. The Subject Device uses an attachment material to permit temporary attachment to the surgical stapler. Both devices are sterile, single use, absorbable implants that absorb over time. The Subject Device absorbs over approximately 120 days, the Predicate Device absorbs over approximately 180 days.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026